Inventor: Rong Xiang

Address: San Diego, CA
No. of patents: 4
Last patent issue date: 08/04/2009

Number	Title	Issue Date
7569552	DNA vaccines against tumor growth and methods of use therof A DNA vaccine suitable for eliciting an immune response against cancer cells comprises a polynucleotide construct operably encoding an a Fra-1 protein, such as a polyubiquitinated human Fra-1 protein, and IL-18, such as human IL-18, in a pharmaceutically acceptable ...	08/04/2009
7279464	DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof A DNA vaccine effective for eliciting an immune response against cells that present a carcinoembryonic antigen (CEA) comprises a DNA operably encoding a CEA and a DNA operably encoding a CD40 ligand, SEQ ID NO:1 and SEQ ID NO: 2, respectively, or its homotrimer, CD4...	10/09/2007
7094410	DNA vaccine against proliferating endothelial cells and methods of use thereof A DNA vaccine effective for inhibiting endothelial cell proliferation comprises a DNA construct operably encoding a vascular endothelial growth factor (VEGF) receptor protein. This invention provides DNA vaccines that encode VEGF receptor-2 (KDR, SEQ ID NO: 2), VEGF...	08/22/2006
6923958	DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof A DNA vaccine effective for eliciting an immune response against cells that present a carcinoembryonic antigen (CEA) comprises a DNA operably encoding a CEA and a DNA operably encoding a CD40 ligand, SEQ ID NO:1 and SEQ ID NO: 2, respectively, or its homotrimer, CD4...	08/02/2005

Comments

No comments for this page